Published in Ann Surg on December 01, 2002
Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg (2006) 2.62
Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review. Br J Cancer (2010) 1.05
Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection. Br J Cancer (2007) 0.99
Colorectal cancer metastasis: in the surgeon's hands? Int Semin Surg Oncol (2005) 0.95
The effects of mechanical forces on intestinal physiology and pathology. Cell Signal (2009) 0.95
Colchicine inhibits pressure-induced tumor cell implantation within surgical wounds and enhances tumor-free survival in mice. J Clin Invest (2008) 0.94
Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of beta1-integrin at threonine 788/789. Am J Physiol Cell Physiol (2008) 0.91
Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method. J Mol Diagn (2006) 0.87
Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques. Cancer Biol Ther (2015) 0.85
Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery. World J Surg (2004) 0.84
Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma. World J Surg (2007) 0.82
Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study. Iran Biomed J (2013) 0.82
SiRNA-mediated reduction of alpha-actinin-1 inhibits pressure-induced murine tumor cell wound implantation and enhances tumor-free survival. Neoplasia (2008) 0.82
Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use? Int J Colorectal Dis (2004) 0.82
Molecular biomarkers for the detection of metastatic colorectal cancer cells. World J Gastroenterol (2014) 0.81
Prognostic value of CEA and CK20 mRNA in the peritoneal lavage fluid of patients undergoing curative surgery for gastric cancer. World J Surg (2014) 0.81
Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice. World J Surg (2004) 0.79
Increased detection rate and potential prognostic impact of disseminated tumor cells in patients undergoing endorectal ultrasound for rectal cancer. Int J Colorectal Dis (2006) 0.79
Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies. Mol Clin Oncol (2013) 0.79
Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma. World J Surg (2005) 0.78
Evolving management of colorectal cancer. World J Gastroenterol (2008) 0.78
Evaluation of intraperitoneal lavage cytology before colorectal cancer resection. Int J Colorectal Dis (2009) 0.77
Safety and diagnostic accuracy of tumor biopsies in children with cancer. Cancer (2014) 0.77
Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review. Clujul Med (2016) 0.75
Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival. Cancer Med (2017) 0.75
Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery. World J Gastrointest Surg (2015) 0.75
Circulating cytokeratin-positive cells and tumor budding in colorectal cancer. World J Clin Oncol (2016) 0.75
Perioperative circulating tumor cell detection: Current perspectives. Cancer Biol Ther (2016) 0.75
Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial. World J Surg (2017) 0.75
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet (1995) 5.77
Micrometastases and survival in stage II colorectal cancer. N Engl J Med (1998) 5.11
Cancer statistics, 1993. CA Cancer J Clin (1993) 3.43
Chemotherapy for colorectal cancer. N Engl J Med (1994) 2.67
Metastatic inefficiency. Adv Cancer Res (1990) 2.40
Surveillance after colorectal cancer resection. Lancet (2000) 2.30
Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer (1995) 2.00
Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res (1994) 1.84
Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol (1994) 1.78
Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg (1993) 1.77
The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer (1994) 1.69
Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res (1998) 1.68
Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg (2000) 1.59
Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer (1996) 1.52
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol (1999) 1.39
Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res (1997) 1.36
Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction. Surgery (1995) 1.31
Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J Surg Res (1990) 1.30
Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol (1999) 1.25
Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol (1998) 1.24
The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer (1996) 1.21
Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg (2000) 1.18
The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer (1997) 1.18
Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer (1998) 1.12
Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene (1995) 1.09
Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br J Cancer (1998) 1.08
Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg (1998) 1.04
Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer (1998) 1.03
Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. Clin Cancer Res (1998) 0.99
Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol (1998) 0.98
7th Jan Waldenström Lecture. The biology of human cancer metastasis. Acta Oncol (1991) 0.98
Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology (2001) 0.97
Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann Surg (2002) 0.95
The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev (1993) 0.94
Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction. Cancer (1996) 0.91
Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA. Life Sci (1997) 0.89
Genetic detection of colorectal cancer cells in circulation and lymph nodes. Dis Colon Rectum (1997) 0.83
Detection of K-ras point mutations in mesenteric venous blood from colorectal cancer patients by enriched polymerase chain reaction and single-strand conformation polymorphism analysis. Jpn J Clin Oncol (1996) 0.83
Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription-polymerase chain reaction in breast cancer patients. Clin Cancer Res (2000) 0.81
[Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma]. Langenbecks Arch Chir (1996) 0.80
Cytokeratin-positive cells in bone marrow in comparison with other prognostic factors in colon carcinoma. Langenbecks Arch Surg (2000) 0.80
Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA. Br J Haematol (1998) 0.80
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol (2002) 5.20
The role of bioreactors in tissue engineering. Trends Biotechnol (2004) 2.56
Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res (2004) 2.55
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat (2004) 2.14
Surgical glove perforation and the risk of surgical site infection. Arch Surg (2009) 2.04
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer (2010) 1.96
Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum (2003) 1.90
Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng (2006) 1.86
The timing of surgical antimicrobial prophylaxis. Ann Surg (2008) 1.85
Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage (2004) 1.84
IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J Leukoc Biol (2002) 1.82
In-hospital delay increases the risk of perforation in adults with appendicitis. World J Surg (2011) 1.72
Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol (2009) 1.67
Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem (2002) 1.66
Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol (2008) 1.65
Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol (2002) 1.59
Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study. J Cell Physiol (2005) 1.49
Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol (2003) 1.49
Detecting pheochromocytoma: defining the most sensitive test. Ann Surg (2006) 1.47
Surgery for ischemic colitis: outcome and risk factors for in-hospital mortality. Int J Colorectal Dis (2014) 1.43
Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells (2005) 1.32
Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum (2002) 1.31
Predominance of high-grade pathway in breast cancer development of Middle East women. Mod Pathol (2005) 1.30
KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin Cancer Res (2004) 1.28
Insurance status and race represent independent predictors of undergoing laparoscopic surgery for appendicitis: secondary data analysis of 145,546 patients. J Am Coll Surg (2004) 1.27
In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials (2005) 1.26
The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat Oncol (2007) 1.24
Nonoperative treatment of splenic rupture in malaria tropica: review of literature and case report. Acta Trop (2002) 1.23
Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol (2012) 1.21
EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers. Clin Cancer Res (2005) 1.21
Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res (2002) 1.21
Rare expression of T-cell markers in classical Hodgkin's lymphoma. Mod Pathol (2005) 1.20
Blunt injury to the thyroid gland: proposed classification and treatment algorithm. J Trauma (2006) 1.19
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer (2010) 1.16
Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial. Clin Cancer Res (2007) 1.15
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies. Int J Oncol (2004) 1.15
Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg (2005) 1.14
NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study. Int J Cancer (2005) 1.13
Accuracy of frozen section analysis versus specimen radiography during breast-conserving surgery for nonpalpable lesions. World J Surg (2008) 1.12
Assessment of intraoperative liver deformation during hepatic resection: prospective clinical study. World J Surg (2010) 1.12
Lubricin reduces cartilage--cartilage integration. Biorheology (2004) 1.12
High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients. World J Surg (2005) 1.11
Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers. Gastroenterology (2005) 1.10
Cell yield, proliferation, and postexpansion differentiation capacity of human ear, nasal, and rib chondrocytes. Tissue Eng (2004) 1.09
[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial. Cancer (2009) 1.08
Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Int J Cancer (2007) 1.08
Tissue microarrays for comparing molecular features with proliferation activity in breast cancer. Int J Cancer (2006) 1.07
Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials (2005) 1.07
Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size. World J Surg (2003) 1.04
Effect of the 50-hour workweek limitation on training of surgical residents in Switzerland. Arch Surg (2010) 1.03
Precultivation of engineered human nasal cartilage enhances the mechanical properties relevant for use in facial reconstructive surgery. Ann Surg (2006) 1.03
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod Pathol (2003) 1.03
Predictive factors for morbidity and mortality in patients undergoing laparoscopic paraesophageal hernia repair: age, ASA score and operation type influence morbidity. World J Surg (2009) 1.02
Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Prostate (2006) 1.01
Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers. BMC Cancer (2012) 1.01
Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model. Tissue Eng (2005) 1.01
Economic burden of surgical site infections at a European university hospital. Infect Control Hosp Epidemiol (2008) 1.00
CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Stem Cells Transl Med (2012) 1.00
TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am J Pathol (2004) 1.00
Characterization and clinical relevance of ALDHbright populations in prostate cancer. Clin Cancer Res (2013) 0.99
Growth factors for clinical-scale expansion of human articular chondrocytes: relevance for automated bioreactor systems. Tissue Eng (2007) 0.99
Local activation of the innate immune system in Buruli ulcer lesions. J Invest Dermatol (2006) 0.99
Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia (2009) 0.98
DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer. Int J Cancer (2002) 0.97
High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One (2013) 0.97
Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis (2012) 0.97
Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. Ann Surg Oncol (2012) 0.96
High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo. Stem Cells (2010) 0.96
Amplification of SKI is a prognostic marker in early colorectal cancer. Neoplasia (2004) 0.96
Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines. Eur J Immunol (2006) 0.95
Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging? Cancer (2012) 0.95
Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors. J Transl Med (2006) 0.95
Protein expression of cancer testis antigens predicts tumor recurrence and treatment response to imatinib in gastrointestinal stromal tumors. Int J Cancer (2011) 0.95